Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Allan Shaw Insider Profile
4 Followers
Allan Shaw, Director at Akari Therapeutics, holds 0.00 shares in Onconetix (Ticker: ONCO), holds 33.53K shares in Akari Therapeutics (Ticker: AKTX), holds ― shares in CalciMedica (Ticker: CALC). Most recently, Allan Shaw Bought ― shares of Onconetix on Aug 23, 2022 for an estimated value of 296.36.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+36.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Allan Shaw holds in companies
Most Profitable Insider Trade
The most profitable trade made by Allan Shaw
Allan Shaw's Trading History
Akari Therapeutics
Jan 02, 2015
Director
Uninformative Buy
―
$111.32K
Onconetix
Aug 23, 2022
Director
Informative Buy
296.36
$0.00
CalciMedica
―
Director
―
―
Vivus
―
―
―
$747.51
List of latest transactions for each holding click on a transaction to see Allan Shaw's performance on stock
You May Also Like
Allan Shaw insider profile FAQ
What is the percentage of profitable transactions made by Allan Shaw?
The percentage of profitable transactions made by Allan Shaw is 50%.
What is the average return per transaction made by Allan Shaw?
The average return per transaction made by Allan Shaw is 36.20%.
What stocks does Allan Shaw hold?
Allan Shaw holds: AKTX, ONCO, CALC, VVUSQ stocks.
What was Allan Shaw’s latest transaction?
Allan Shaw latest transaction was an Informative Buy of $296.36.
What was Allan Shaw's most profitable transaction?
Allan Shaw’s most profitable transaction was an Informative Sell of ONCO stock on August 23, 2022. The return on the trade was 72.40%.
What is Allan Shaw's role in Akari Therapeutics?
Allan Shaw's role in Akari Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.